 that patients treated with foamed
liquid sclerosants are commonly exposed to cerebrovascular gas bubbles. In a series of 60 high-risk patients with

34S Gloviczki et al

middle cerebral artery bubble emboli during or after treatment, however, there was no evidence of cerebral or cardiac
microinfarction.
Although rare, allergic reactions and anaphylaxis after injection of a sclerosing solution can occur, and it is
essential to have an